About MELODIOL GLOBAL HEALTH LIMITED Company

Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following geographical segments: Europe includes Creso Pharma Switzerland GmbH, Canada includes the operating companies; Mernova Medicinal Inc, Halucenex Life Sciences Inc., Creso Impactive Ltd, United States of America, and Creso Pharma Limited in Australia. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.